CABA: Cabaletta Bio Inc

CABA Notícias

• Benzinga 15:07 What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Sarepta Therapeutics (NASDAQ:SRPT), Capricor Therapeutics (NASDAQ:CAPR)
• Benzinga 12:36 FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)
• Investing 11:49 Cabaletta Bio stock price target reiterated on strong clinical data
• Investing 13:05 H.C. Wainwright reiterates buy rating on Cabaletta Bio stock
• Investing 15:10 Cabaletta Bio stock tumbles after pricing $100 million public offering
• Investing 14:03 Cabaletta Bio prices $100 million public offering of shares and warrants
• Investing 10:21 Cabaletta Bio announces public offering of common stock and warrants
• Investing 10:13 Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
• Investing 10:05 Cabaletta reports positive clinical data for autoimmune cell therapy
• Seeking Alpha 15:09 Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL)
• Investing 12:20 Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
• Investing 21:52 Cabaletta Bio announces option repricing for key personnel
• Investing 11:20 Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts